Images of medication Zepbound Generic Name tirzepatide Strength 12.5 mg/0.5 mL injection (single-dose vial) Availability Prescription only Drug Class GLP-1 Drugs CSA Schedule Not a controlled drug Labeler / Supplier Eli Lilly and Company National Drug Code (NDC) 00002-1423 More about Zepbound (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (713) Drug images Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
These improvements included blood pressure, triglycerides, and high-sensitivity C-reactive protein across various doses
Novo Nordisk, the producer of Ozempic, faces legal challenges related to the medications side effects and marketing practices
At this point, we are exploring this in clinical trials, and if this therapy is successful, a patient would ultimately be able to process copper normally, stop taking D-penicillamine, and eat a normal dietchocolate and all
Well take the time to understand your goals, evaluate your bite, and determine whether now is the right time to begin treatment
.png)
.png)
.png)
